Ionis Pharmaceuticals IONS Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's other operating expenses?
- Ionis Pharmaceuticals (IONS) reported other operating expenses of -1.1% in Q4 2025.
- What does other operating expenses mean?
- Miscellaneous operating costs not categorized as R&D or SG&A.
- How do you interpret other operating expenses?
- Unexpected increases may signal inefficiencies or rising overhead costs that require further investigation.
- How does other operating expenses compare across companies?
- Standard line item in operating expense disclosures across all industries.